CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 94 enrolled
Drug / intervention
Medical Device Usage and Evaluation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04256512
NCT04256512N/ACompleted

Cryotherapy to Prevent Taxane-Induced Sensory Neuropathy of the Hands and Feet

Mayo Clinic·interventional·Posted Feb 5, 2020·Updated Jul 28, 2025

In Brief

A clinical study evaluating Medical Device Usage and Evaluation and Questionnaire Administration for Breast Carcinoma. Completed, enrolled 94 participants across 1 site.

Detailed Summary

This clinical trial investigates the effect and tolerability of cryotherapy and to evaluate whether they can prevent or improve taxane-induced sensory peripheral neuropathy in breast cancer patients. Cryosurgery, also known as cryoablation or cryotherapy, kills tumor cells by freezing them. Patients receiving cryotherapy during infusion of taxane therapy may have lower incidence of peripheral neuropathy, better physical function, and higher quality of life as compared to patients previously reported in literature.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 5, 2020
Enrollment StartMar 10, 2020
Primary CompletionJan 18, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 6.4 years ago

Interventions

Medical Device Usage and Evaluationdevice

Wear Elasto Gel Therapy Mittens and Foot Wraps

Questionnaire Administrationother

Ancillary studies